Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -6559.27% is 2448% below its 1-year average of -257.44%, near the low end of its 1-year range (-6559.27%–0.00%).
2447.87% below its 12-month average of -257.44%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1287.21%.
NET PROFIT MARGIN
-6559.27%
NET PROFIT MARGIN AVG TTM
-257.44%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2447.87%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Canton Strategic Holdings Inc
Market Cap
$184.71M
Net Profit Margin
-6559.27%
TTM Avg
-257.44%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$184.76M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$182.13M
Net Profit Margin
3202.50%
TTM Avg
1601.25%
3Y Avg
554.42%
5Y Avg
279.00%
Market Cap
$191.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$177.93M
Net Profit Margin
-8.95%
TTM Avg
-22.31%
3Y Avg
-22.43%
5Y Avg
-24.59%
Market Cap
$194.36M
Net Profit Margin
-36.80%
TTM Avg
-24.29%
3Y Avg
-59.84%
5Y Avg
-44.50%
Market Cap
$175.06M
Net Profit Margin
0.00%
TTM Avg
-2904.41%
3Y Avg
-1452.20%
5Y Avg
-968.14%
Market Cap
$174.03M
Net Profit Margin
-117.04%
TTM Avg
-61.51%
3Y Avg
-173.42%
5Y Avg
-194.84%
Market Cap
$173.23M
Net Profit Margin
-229.20%
TTM Avg
-206.03%
3Y Avg
-659.07%
5Y Avg
-1951.89%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canton Strategic Holdings Inc (CNTN) | $184.71M | -6559.27% | -257.44% | 0.00% | 0.00% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.13M | 3202.50% | 1601.25% | 554.42% | 279.00% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $191.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Journey Medical Corporation (DERM)vs › | $177.93M | -8.95% | -22.31% | -22.43% | -24.59% |
| RxSight, Inc. (RXST)vs › | $194.36M | -36.80% | -24.29% | -59.84% | -44.50% |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.06M | 0.00% | -2904.41% | -1452.20% | -968.14% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.03M | -117.04% | -61.51% | -173.42% | -194.84% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | -229.20% | -206.03% | -659.07% | -1951.89% |
| Cue Biopharma, Inc. (CUE)vs › | $173.18M | -435.83% | -267.41% | -1429.19% | -1238.68% |
Operating Margin
0.0%
Net Profit Margin
-6559.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1287.21% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
